双极性障碍患者的认知缺陷NMDA受体调节治疗:叙述性综述
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。N-甲基-d-亚斯巴酸受体 (NMDAR) 调节剂在改善双相情感障碍的认知缺陷方面表现有前途. 需要进一步的研究和更长的试验来证实这些药物的有效性和安全性.
科学领域
- 神经科学
- 精神病学
- 药理学
背景情况
- 认知障碍是双相情感障碍的主要挑战,影响日常功能和治疗结果.
- 目前治疗双相情感障碍的方法往往无法改善甚至恶化认知功能.
- 谷氨酸系统,特别是N-甲基-d-亚斯巴酸受体 (NMDARs),与认知缺陷有关.
研究的目的
- 审查NMDAR调节用于增强双相情感障碍的认知功能.
- 突出动物研究和NMDAR调节剂早期临床试验的发现.
主要方法
- 使用PubMed和谷歌学者进行了系统的文献搜索.
- 按照PRISMA的指导方针,确定了针对双相情感障碍认知缺陷的NMDAR对手的相关研究.
主要成果
- 作为一种补充疗法,Memantine在各种疾病中显示出认知改善,包括治疗耐药的双相情感障碍.
- 在双相情感障碍患者中,胺注入对处理速度和语言学习有好处.
结论
- 调节NMDAR的药物具有显著的潜力,可以改善双相情感障碍的认知功能.
- 需要进一步的多中心研究来评估NMDAR抗剂的长期疗效和安全性.
- 针对NMDAR可能有助于解决持续的认知障碍,如注意力,执行功能和记忆力缺陷.
相关概念视频
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...